Continuation of amiodarone therapy despite type II amiodarone-induced thyrotoxicosis

Drug Safety : an International Journal of Medical Toxicology and Drug Experience
Laurent UzanDenis Duboc

Abstract

Amiodarone is a powerful antiarrhythmic drug; however, its use may be complicated by thyrotoxicosis. When this occurs, clinicians must balance the continuation of amiodarone for antiarrhythmic purposes, and the discontinuation of treatment in order to prevent aggravation of the thyrotoxicosis. We studied the consequences of continuation or cessation of amiodarone in patients with type II amiodarone-induced thyrotoxicosis. Consecutive patients who developed type II amiodarone-induced thyrotoxicosis between September 1997 and September 2000 were studied. Amiodarone was continued in patients with previous ventricular arrhythmia or supraventricular arrhythmia associated with severe haemodynamic changes and was withdrawn in the other patients. In patients with persistent, severe symptomatic thyrotoxicosis, corticosteroids were added to therapy. Thirteen patients were studied (nine with previous atrial fibrillation/flutter and four with ventricular tachycardia). Amiodarone treatment was continued in ten patients, including eight patients who received corticosteroids, and was temporarily halted in three patients. All patients recovered, with no difference in the duration of thyrotoxicosis between the two groups. Corticosteroid treatme...Continue Reading

References

Oct 1, 1975·The Journal of Clinical Endocrinology and Metabolism·J C SavoieF Leger
Jul 25, 1992·BMJ : British Medical Journal·P H DaviesM C Sheppard
Dec 1, 1984·European Journal of Clinical Investigation·A F LegerJ C Savoie
Jan 7, 1998·The American Journal of Cardiology·K SakataK Ishikawa
Sep 14, 1999·Journal of the American College of Cardiology·M A WoodL S Liebovitch
Apr 6, 2000·Pacing and Clinical Electrophysiology : PACE·T ChalvidanP Djiane
Feb 15, 2001·The New England Journal of Medicine·I Klein, K Ojamaa
Mar 7, 2001·The Journal of Clinical Endocrinology and Metabolism·G H Daniels
Feb 13, 2002·Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing·Athanasios G ManolisCostas G Tsatiris
Sep 3, 2003·Journal of Cardiovascular Electrophysiology·Paul Dorian, Iqwal Mangat
Aug 17, 2004·Journal of Cardiac Failure·Raymond L BenzaUNKNOWN OPTIME-CHF Investigators
Jun 2, 2005·JAMA : the Journal of the American Medical Association·Oussama M WazniAndrea Natale

❮ Previous
Next ❯

Citations

Nov 28, 2009·Best Practice & Research. Clinical Endocrinology & Metabolism·Silvia A Eskes, Wilmar M Wiersinga
Sep 21, 2006·Clinical Endocrinology·Leandro Arthur DiehlWilmar M Wiersinga
May 4, 2011·Clinical Endocrinology·Sheba AhmedThera P Links
Jun 19, 2007·Journal of the American College of Cardiology·David ConenStefan Osswald
Aug 16, 2016·Thyroid : Official Journal of the American Thyroid Association·Douglas S RossMartin A Walter
Nov 26, 2009·Nature Reviews. Endocrinology·Janna Cohen-LehmanIrwin Klein
Sep 10, 2013·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Marius N StanRebecca S Bahn
Jan 10, 2019·Health Science Reports·Jennifer M YamamotoFrancisco J Cordova
Dec 18, 2020·Frontiers in Cardiovascular Medicine·Marvin Wei Jie Chua, Shao Feng Mok
Sep 22, 2018·Annales d'endocrinologie·Salwan MaqdasyIgor Tauveron
May 16, 2020·Annales d'endocrinologie·Louis SchubertLionel Groussin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.